Monday, February 19, 2018

Lung Transplant Rejection Global Clinical Trials Review H2 2017: Ken Research

GlobalData'sclinical trial report, Lung Transplant Rejection Global Clinical Trials Review, H2, 2017" provides an overview of Lung Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical trials on Lung Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months

Key Topics Covered in the Report:
Lung Transplant Rejection Global Clinical Trials
Global Lung Transplant Rejection Clinical Trials Market Size
Global Lung Transplant Rejection Clinical Trials Market Trends
Global Lung Transplant Rejection Clinical Trials Market Outlook
Global Lung Transplant Rejection Clinical Trials Market Demand
Global Lung Transplant Rejection Clinical Trials Market Forecast
Global Lung Transplant Rejection Clinical Trials Market
Europe Lung Transplant Rejection Clinical Trials
Global Lung Transplant Rejection Clinical Trials Market
Global Lung Transplant Rejection Clinical Trials Market Value

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Friday, February 16, 2018

Indonesia Pharmaceutical Market Outlook to 2022: Ken Research

Indonesia Pharmaceutical Market Outlook to 2022 - By Therapeutic Segment (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology), By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region" provides information on market size for Indonesia Healthcare and pharmaceutical.

The report covers aspects such as healthcare market segment (by hospitals, pharmaceuticals, medical devices and clinical laboratory), pharmaceutical market segment (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region), competitive landscape of major players in the Indonesia pharmaceutical market, and covering competitive landscape of major pharmaceutical companies including PT Kalbe Farma, PT Sanbe Farma, PT SOHO Global Health, PT Dexa Medica, PT Pharos, PT Kimia Farma, PT Tempo Scan Pacific Tbk, PT Merck Tbk, Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.
Indonesia Pharmaceutical Market
Indonesia Pharmaceutical market has registered an increase in the revenue at a CAGR of ~% from USD ~ billion in 2012 to USD ~ billion in 2017.
By Therapeutic Segment: Anti-infective drug sale has contributed to the largest share of ~% in the revenue share of Indonesia Pharmaceutical industry in 2017. This is mainly due to high prevalence of bacterial and communicable diseases. This is followed by Gastrointestinal and metabolism drugs with ~%, cardiovascular system drugs with ~%, Central Nervous system drugs with ~%, Respiratory system drugs with ~%, Musculoskeletal system drugs with ~%, dermatology drugs with ~%, genitourinary and hormonal drugs with ~%, blood related drugs with ~%, oncology with ~% and rest of the therapeutic segments with ~% of the revenue share in 2017.
By Domestic and International Players: Domestic players have accounted for ~% of the revenue in Indonesia pharmaceutical market in 2017 driven by the implementation of JKN (National Health Insurance System) in 2014. International players have captured ~% of the revenue share in 2017 driven by favorable government norms for foreign ownership.
By Generic and Patented Drug: Generic drugs have accounted for the major revenue share of ~% in 2017 driven by the increased demand from government run hospitals and clinics. The share of patented drugs has increased from ~% in 2013 to ~% in 2017. Further, ethical generic drugs have accounted for ~% of the Indonesia generic drug market revenue in 2017 followed by free sale drugs with ~% and unbranded drug sale with ~%.
By OTC and Prescription Drugs: The Prescription drugs sales have accounted for ~% of the revenue share in Indonesia Pharmaceuticals Market. OTC drugs have accounted for ~% of the revenue share in 2017. This segment is driven by increased tendency of Indonesians to treat them and take self medication
By Domestic Sales and Exports: Domestic sales have accounted for a majority revenue share of ~% in 2017 whereas exports have accounted for a small share of ~%. The domestic market is dominated by the sale of low priced ethical generic medicines.
Indonesia Pharmaceutical Market Competition Overview
Indonesia Pharmaceutical market is dominated by domestic players which control ~% of the market in 2017. Recent favorable government regulations have facilitated the entry of foreign players in the space. There are 206 pharmaceutical companies (182 domestic and 24 international companies) located in Indonesia and ~% of them are located in Java in 2016. These players compete on the basis of distribution network, product portfolio, marketing activities and research and development. The domestic players dominate the generic drug and over the counter drug segment. International players have better expertise, skilled labor and infrastructure to produce such medicines at competitive prices. While domestic companies dominate the market for low cost generic drugs, multinational players have taken over high-demand, specialized segments and pharmaceuticals services ranging from capsule provision to instrumentation and packaging.
Indonesia Pharmaceutical Market Future Potential
Indonesia pharmaceutical industry is expected to increase from USD ~ billion in 2018 to USD ~ billion at a growth rate of ~%. The industry growth will be led by Indonesia’s large population and growing middle-income class, supportive government policies and higher investment in the industry. With the increase in incidence of communicable diseases such as HIV, TB, therapeutic segments such as anti infectives and respiratory are expected to grow. Major companies are expected to increase investment in nutritional and herbal medicines due to changing preference in the industry. Apart from manufacturing generic and patented drugs, pharmaceutical companies will shift focus to other niche segments such as combined dosages, novel drug delivery areas. Further in order to overcome the shortcomings, Contract Development and Manufacturing Organizations (CDMOs) will emerge as an attractive resource for manufacturers seeking to expand their capacities.
Key Topics Covered in the Report:
  • Indonesia Healthcare Market Size, 2012-2017
  • Indonesia Pharmaceutical Market Size, 2012-2017
  • Indonesia Pharmaceutical Market Segmentation (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region)
  • Trends and Developments in Indonesia Pharmaceutical Market
  • Issues and Challenges in Indonesia Pharmaceutical Market
  • Government Initiatives, Rules and Regulations in Indonesia Pharmaceutical Market
  • Indonesia Pharmaceutical Market Competitive Landscape
  • Indonesia Pharmaceutical Future Outlook and Projections, 2018-2022
  • Indonesia Healthcare Future Outlook and Projections, 2018-2022
  • Analyst Recommendations
  • Macro-economic Factors Impacting Indonesia Healthcare Market
Source: https://www.kenresearch.com/healthcare/pharmaceuticals/indonesia-pharmaceutical-market/143542-91.html
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249

Global Lung Infections Clinical Trials Market Research Report to 2017: Ken Research

GlobalData'sclinical trial report, Lung Infections Global Clinical Trials Review, H2, 2017" provides an overview of Lung Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Lung Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months

Key Topics Covered in the Report:
Global Lung Infections Clinical Trials Market Research Report
Global Lung Infections Clinical Trials Market Size
Global Lung Infections Clinical Trials Market Trends
Global Lung Infections Clinical Trials Market Forecast
Global Lung Infections Clinical Trials Market Outlook
Global Lung Infections Clinical Trials Market Share
Global Lung Infections Clinical Trials Market
Global Lung Infections Clinical Trials Industry Research
 Europe Lung Infections Clinical Trials Market Volume
US Lung Infections Clinical Trials Market Revenue

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Indonesia Healthcare Market has been driven by Increase in Foreign Direct Investment and favourable Government Initiatives: Ken Research

Implementation of JKN (National Health Insurance System) by the government, growing foreign investment in the private hospital sector, expansion of service and product portfolio by major private hospital chains and pharmaceutical companies were the key factors driving growth in Indonesia Healthcare Market.
The Indonesia healthcare market has shown a positive incline during 2012-2017 but with respect to the expanding population of Indonesia, the market is still underserved especially in the underdeveloped and rural areas as of 2017.
The implementation of JKN scheme by the government has led to rise in demand for primary healthcare facilities and increased generic drug sale. This has further led to increase in number of outpatients and improvement in margins mainly from upgrades for standard JKN fees and services.
The industry has undergone various deregulation programs which has encouraged foreign investment in the industry. For instance, the government removed pharmaceutical industry from its negative investment list implying 100% foreign ownership is allowed. Further, foreign players are allowed to hold 67% stake in both general and specialty hospitals. Foreign investors such as Malaysia-based Creador injected USD 45 million in Medikaloka Hermina, the operator of the Hermina Hospital Group. Netherlands has accounted for the largest share of USD 10 million in the total foreign investment of USD 14.3 million during the first half of 2017.
The market has witnessed enhancing innovation in nutritional health segment and biopharmaceuticals due to growing prevalence of lifestyle diseases such as diabetes, hypertension and obesity. International companies have benefitted from rising demand in medication for chronic diseases such as Tuberculosis, HIV and others. Furthermore, increase in demand for generic medicines has led the major players in the industry to expand their production capabilities. In order to capture the market potential, the industry has observed various mergers and acquisitions over the last few years. Further, there are startups such as PesanLab which offers a booking service for laboratory testing, or Homecare24 which offers on-demand home care services. This will further lead to integration of healthcare services in the country.
The report titled “Indonesia Healthcare Market Outlook to 2022 - by Hospitals, Clinical Laboratories, Pharmaceutical, Pharmacy Chains, Medical Device Segment” by Ken Research suggested a growth at a CAGR of 9.6% in revenue in Indonesia Healthcare Market by 2022.
Key Topics Covered in the Report:
Medical Devices Market Indonesia
Indonesia Healthcare Statistics
Diabetes Prevalence Indonesia
Pharmaceutical Market Indonesia
Obese Population Indonesia
Number of Hospitals Indonesia
Healthcare Spending Indonesia
Number of Puskesmas Indonesia
Medical Device Imports Indonesia
Type of Medical Devices Indonesia
Tuberculosis Prevalence Indonesia
For more information on the research report, refer to below link:
Related Reports by Ken Research
Contact:         
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Thursday, February 15, 2018

Lumbar Hernia/Bleichner'shernia Global Clinical Trials Review H2 2017: Ken Research

GlobalData'sclinical trial report, Lumbar Hernia/Bleichner'sHernia Global Clinical Trials Review, H2, 2017" provides an overview of Lumbar Hernia/Bleichner'sHernia clinical trials scenario. This report provides top line data relating to the clinical trials on Lumbar Hernia/Bleichner'sHernia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months

Key Topics Covered in the Report:
Lumbar Hernia/Bleichner'shernia Global Clinical Trials Review H2
Global Lumbar Hernia/Bleichner'shernia Clinical Trials Market
Global Lumbar Hernia/Bleichner'shernia Market Size
Global Lumbar Hernia/Bleichner'shernia Market Trends
Global Lumbar Hernia/Bleichner'shernia Clinical Trials Market Growth
Global Lumbar Hernia/Bleichner'shernia Clinical Trials Market Revenue
Global Lumbar Hernia/Bleichner'shernia Clinical Trials Market Outlook
Lumbar Hernia/Bleichner'shernia Global Clinical Trials Europe
Global Lumbar Hernia/Bleichner'shernia Industry Research
Global Lumbar Hernia/Bleichner'shernia Market Volume

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Evolution in E-Commerce and Digitalization to Boost Retailing Market in Turkey: Ken Research

Retailing in Turkey Market Shares Summary & Forecasts to 2021 provides a comprehensive analysis of retailing market, various categories in retailing market, leading players in various sectors in retailing market, and future of retail market in Turkey.

Retail Market Over view: Retailing market in Turkey includes clothing, footwear, books, news and stationery, electrical and electronics, food and grocery, health and beauty, furniture and floor coverings, home and garden products, music, video and entertainment software, sports and leisure equipment, jewellery, watches and accessories, and luggage and leather goods. The health and beauty sector in Turkey is expected to witness the continuing double digit growth in the next few years due to increase in aging population, more women in the workforce, and consumers’ awareness of health and wellness benefits. Turkey lags in the e-commerce market and started to develop in the area of digitalization. Turkey’s relatively high rates of mobile Internet and social-network combined with a young and growing urban population, encourages the e-commerce environment.

The rapid urbanization has encouraged the consumer electronics retailers in the country and the sales of smartphones are growing rapidly. The leading domestic players in Turkey’s consumer electronics retailers are Teknosa, Bimeks, Vestel, Vatan Computer, and Koç Holding’s retail banners, Arcelik and Beko. Metro Group is the leading international company in Turkey’s consumer electronics retailers. High-end electronics and smart phones in Turkey will drive the growth in the electrical retail sector in the next few years.
The apparel and footwear segment in Turkey is fragmented with the presence of strong domestic players. Turkish consumers spend more on apparel and footwear and it is one of the fastest-growing retail categories in retail in Turkey. Waikiki is the leading domestic apparel and footwear retailer in Turkey and also operates in other countries. It is one of the best-established retailers in the apparel and footwear market and enjoys strong brand awareness among consumers. Turkey has a relatively young population with westernized tastes in fashion that creates a favourable environment for international fast-fashion retailers. The online purchase of clothing and footwear is increasing steadily and this trend will continue in the next few years. The major clothing and footwear retailers in Turkey are expanding their market by opening new stores within the country.

According to the researchers, the Turkish retail industry witnessed a slight recovery, however, the stagnation still continues. The establishment of the number of shopping malls will continue to be slow and the rental income will decrease. The companies which invested fully in the domestic market need to venture into foreign markets for more growth opportunities. Turkey is a challenge to international retailers who looking for growth in retail markets. Macro factors such as economic expansion, increase in young population, strong retail sales growth, and a fragmented retail sector, go hand in hand for sophisticated retailers. They are benefitted from growth and merged opportunities in the country. As Turkey’s economic growth slowed and its political instability increased, many large international retailers began to withdraw from the retail market. Turkey’s modern retail sector is led by the domestic players, who create a highly competitive market.

Turkish consumers spend on groceries despite slowing economic growth and the expenditure on food and non-alcoholic beverages has increased. The largest sector in the Turkish retail industry is food and grocery which contributes to a major share in the retail industry. Modernization, urbanization, and preference towards shopping in organized retail outlets are encouraging the growth in the food and grocery sector. The largest fastest-growing channel for food and grocery sales in Turkey are hypermarkets, supermarkets and hard-discounter. Online channel is at a budding stage with only top retailers competing in the online sales of foods and grocery. Food and grocery will also witness a continuing growth in the next few years. BIM, A101 and Sok are top three leading grocery discounters in Turkey which hold a mojor share in the retail industry. The discounters channel in Turkey is growing at the expense of supermarkets, hypermarkets and traditional grocery retailers because they provide proximity shopping, one-stop shopping and low prices.

Leading Players and Future of Retail Market in Turkey: More than half the retail market in Turkey is operated by the small independents. The retail sector is more concentrated with leading companies expanding their businesses and market shares. Majority of the international retailers are considering withdrawing their business from the Turkish retail market in view of the recent political events. E-commerce occupies a relatively low share in the Turkish retail market and has scope for future expansion. The leading players such as Hepsiburada are strengthening their market shares; retailers such as Migros and Teknosa are expanding their business by opening multi-channel operations. The leading comapines in the retail industry in Turkey are LC Waikiki, DeFacto, Koton, H&M, Boyner, Zara, YKM, BIM, Migros, A101, Carrefour, Sok, Vatan, Teknosa, Arcelik, Media Markt, Bimeks, Gratis, Watsons, Avon, Yves Rocher, Amway, Bellona, Tekzen, IKEA, Koctas, Bauhaus. Domestic retailing companies in Turkey such as Waikiki lead in apparels, Teknosa in consumer electronics and Hepsiburada in e-commerce.

Consumers today buy everything from food, clothing, smartphones and or cosmetics on Hepsiburada.com. The company Hepsiburada.com, is owned by Turkish conglomerate Dogan Group, which is referred to as the Amazon of Turkey. It is the leading e-commerce retailer in its domestic market. The underlying uncertainty is affecting the Turkey’s economic growth and consumer confidence in recent years. The country’s economy witnessed resilience and started flourishing amid high inflation and volatility of the Turkish currency. The retail industry in Turkey is expected to grow gradually by the year 2021 with the recovery of the country’s GDP, rising employment, increasing wages, and increasing household consumption expenditure.

Key Topics Covered in the Report:
  • Turkey Retailing Market Report
  • Turkey Retailing Market Analysis
  • Turkey Retail Industry Market Outlook
  • Turkey E-commerce industry analysis
  • Online shopping trends Turkey
  • Turkey Retailing Market Leading Players
  • Smartphones penetration in Turkey
  • Apparel market research Turkey
  • Food and Beverages Retail Sector Turkey
  • Electricals and Electronics Sales Turkey
  • Consumer Electronics Retailers Turkey
  • Apparel and Footwear Retail Sales Turkey
  • Turkey retail sector opportunities
  • Turkey retail industry competition
To know more, click on the link below:

https://www.kenresearch.com/consumer-products-and-retail/textile-apparel-and-footwear/retailing-in-turkey-market-shares-summary/142707-95.html

Related Reports

Home Retailing in Turkey Market Shares Summary & Forecasts to 2021
Health & Beauty Retailing in Turkey Market Shares Summary & Forecasts to 2021

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com
0124-4230204

Global Organic Food and Beverage Market is Driven by Growing Sales of Organic Tea, Coffee and Non-Vegan Products and Shift towards Organic Baby Food Products: Ken Research Analysis

Expanding product portfolio with launch of new variants in organic coffee and tea segment, rising cases of genetically modified meat, fish and poultry products, introduction of country specific online sales portal by manufacturers, retails and distributors and quick shift towards organic baby food products will be the key factors driving growth in global organic food and beverage market.
 
Global urban population has increased at a steady pace over the review period (2012-2017). Coupled with increasing percentage of literates in the overall population, there has been a significant shift of preference from conventional food products towards organic food products. Approximately 2% of overall agricultural land was cultivated for organic food and beverage products in 2016 and every major region has witnessed an increase in organic production volume. Americas has been the biggest market in terms of organic food and beverage retail sales followed by Europe, APAC and Middle East & Africa. Demand has increased on the back of growing base of Millennial, higher per capita income in major markets, presence of well established players and expanded distribution network in these regions.

Global online retailing of organic food and beverages has been a major trend in 2016 and 2017. Online retailers in Europe especially in Germany, France and United Kingdom have generated enormous revenue from this sales channel. In Germany, the online retail sales have grown at CAGR of 3.6% during 2012 to 2016.  Japan and China have also fared well with annual growth rate of online retail sales of 1.4% and 43.2% respectively in 2016. Leading manufacturers have analyzed the emerging market expansion opportunity in online retailing. Major online retailers worldwide include Organic Shop, Vitacost, Sunfood, 3 Bears Organic amongst various others.

Organic tea and coffee have showcased promising growth and potential in organic beverage category. Global consumption of organic tea and coffee has increased on account of increase in caffeine intake by the urban population especially in the age bracket of 25 years and above. Conventional tea and coffee are amongst one of the most chemically treated products. Consumers are shifting from conventional to organic tea and coffee because of the added antioxidants found in them.  This market has grown at a CAGR of 29.4% over 2011 to 2016 in terms of value. Latin American countries have been the major producers of organic coffee in 2017. These include Mexico, Brazil, Colombia, El Salvador, and Guatemala.

Organic baby food demand has increased manifold due to increase in parental predilection towards right nutrition and healthier food intake for their babies, expanded food product range, well developed distribution channel of major manufacturer, high cases of baby food adulteration and increase in awareness of the nutritional benefits of pure organic products. The organic baby food market has been valued at over USD 5,000 million in 2016, growing at an approximate CAGR of over 10% for next 5 years.

The report titled “Global Organic Food and Beverage Market by Product Categories (Organic Fruits and Vegetables, Organic Dairy Products, Organic Meat, Fish and Poultry, Organic Bread and Bakery, Organic Tea and Coffee)-Outlook To 2022” by Ken Research suggested a growth at a CAGR of 7.5% in retail sales in Global Organic Food and Beverage Market by 2022.

Key Topics Covered in the Report:
World Organic Food Industry
Organic Farming Market
Americas Organic Food Market 
Global Organic Fruits and Vegetables Market
Organic Fruits and Vegetables Market
Organic Dairy Market Trends
Organic Meat, Fish, Poultry Market
Organic Break Market Growth
Organic Bakery Market
Organic Coffee Market
Organic Tea Market
Organic Milk Market
USA Organic Food Beverage Market
Germany Organic Food Beverage Market
India Organic Food Beverage Market
Value Chain Organic Food Market

For more information on the research report, refer to below link:

Related Reports by Ken Research


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249